These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 33687449)

  • 1. Saliva Tests Comparable With Nasal Swabs for SARS-CoV-2 Detection.
    Abbasi J
    JAMA; 2021 Mar; 325(10):924. PubMed ID: 33687449
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined Self-Collected Anterior Nasal and Oropharyngeal Specimens versus Provider-Collected Nasopharyngeal Swabs for the Detection of SARS-CoV-2.
    Shakir SM; Barker AP; Hillyard DR; Gilmore N; Barrett JW; Orlandi RR; Hanson KE
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087437
    [No Abstract]   [Full Text] [Related]  

  • 3. Saliva-based testing for diagnosis of SARS-CoV-2 infection: A meta-analysis.
    Kivelä JM; Jarva H; Lappalainen M; Kurkela S
    J Med Virol; 2021 Mar; 93(3):1256-1258. PubMed ID: 33079392
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of Specimen Types and Saliva Stabilization Solutions for SARS-CoV-2 Testing.
    Griesemer SB; Van Slyke G; Ehrbar D; Strle K; Yildirim T; Centurioni DA; Walsh AC; Chang AK; Waxman MJ; St George K
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33674284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hock-a-loogie saliva as a diagnostic specimen for SARS-CoV-2 by a PCR-based assay: A diagnostic validity study.
    Fan J; Yu F; Wang X; Zou Q; Lou B; Xie G; Yang X; Chen W; Wang Q; Zhang D; Wang R; Feng B; Dong Y; Huang L; Teng Y; Deng Z; Yu L; Xu K; Sheng J; Zheng S; Chen Y
    Clin Chim Acta; 2020 Dec; 511():177-180. PubMed ID: 33068630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saliva Alternative to Upper Respiratory Swabs for SARS-CoV-2 Diagnosis.
    Byrne RL; Kay GA; Kontogianni K; Aljayyoussi G; Brown L; Collins AM; Cuevas LE; Ferreira DM; Fraser AJ; Garrod G; Hill H; Hughes GL; Menzies S; Mitsi E; Owen SI; Patterson EI; Williams CT; Hyder-Wright A; Adams ER; Cubas-Atienzar AI
    Emerg Infect Dis; 2020 Nov; 26(11):2770-2771. PubMed ID: 32917294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of SARS-CoV-2 from Saliva as Compared to Nasopharyngeal Swabs in Outpatients.
    Kandel C; Zheng J; McCready J; Serbanescu MA; Racher H; Desaulnier M; Powis JE; Vojdani K; Finlay L; Sheldrake E; Vermeiren C; Katz K; McGeer A; Kozak R; Goneau LW
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33212817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 detection by fluorescence loop-mediated isothermal amplification with and without RNA extraction.
    Taki K; Yokota I; Fukumoto T; Iwasaki S; Fujisawa S; Takahashi M; Negishi S; Hayasaka K; Sato K; Oguri S; Nishida M; Sugita J; Konno S; Saito T; Teshima T
    J Infect Chemother; 2021 Feb; 27(2):410-412. PubMed ID: 33214073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary Detection of COVID-19.
    Caulley L; Corsten M; Eapen L; Whelan J; Angel JB; Antonation K; Bastien N; Poliquin G; Johnson-Obaseki S
    Ann Intern Med; 2021 Jan; 174(1):131-133. PubMed ID: 32857591
    [No Abstract]   [Full Text] [Related]  

  • 10. Sensitivity of nasopharyngeal, oropharyngeal, and nasal wash specimens for SARS-CoV-2 detection in the setting of sampling device shortage.
    Calame A; Mazza L; Renzoni A; Kaiser L; Schibler M
    Eur J Clin Microbiol Infect Dis; 2021 Feb; 40(2):441-445. PubMed ID: 32939576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The accuracy of healthcare worker versus self collected (2-in-1) Oropharyngeal and Bilateral Mid-Turbinate (OPMT) swabs and saliva samples for SARS-CoV-2.
    Tan SY; Tey HL; Lim ETH; Toh ST; Chan YH; Tan PT; Lee SA; Tan CX; Koh GCH; Tan TY; Siau C
    PLoS One; 2020; 15(12):e0244417. PubMed ID: 33326503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-Collected Anterior Nasal and Saliva Specimens versus Health Care Worker-Collected Nasopharyngeal Swabs for the Molecular Detection of SARS-CoV-2.
    Hanson KE; Barker AP; Hillyard DR; Gilmore N; Barrett JW; Orlandi RR; Shakir SM
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32817233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the newly developed BioFire COVID-19 test for SARS-CoV-2 molecular detection.
    Liotti FM; Menchinelli G; Marchetti S; Morandotti GA; Sanguinetti M; Posteraro B; Cattani P
    Clin Microbiol Infect; 2020 Dec; 26(12):1699-1700. PubMed ID: 32735938
    [No Abstract]   [Full Text] [Related]  

  • 14. Saliva in the Diagnosis of COVID-19: A Review and New Research Directions.
    Fernandes LL; Pacheco VB; Borges L; Athwal HK; de Paula Eduardo F; Bezinelli L; Correa L; Jimenez M; Dame-Teixeira N; Lombaert IMA; Heller D
    J Dent Res; 2020 Dec; 99(13):1435-1443. PubMed ID: 32936047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the pain experienced with anterior nasal swabs and nose and throat swabs in children.
    Harwood R; Rad L; Larru B; Kelly C; Kenny S; ;
    Arch Dis Child; 2022 Feb; 107(2):207. PubMed ID: 34728461
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of three commercial SARS-CoV-2 assays for pooled testing of deep throat saliva for surveillance of patients attending general outpatient clinics.
    Ho YI; Wong AH; Tang KPS; Wong RCW; Leung ECM; Lai RWM
    J Med Virol; 2021 Apr; 93(4):1917-1919. PubMed ID: 33428782
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of saliva as an alternative diagnostic specimen source for SARS-CoV-2 detection by RT-dPCR.
    Sui Z; Zhang Y; Tu S; Xie J; Huang W; Peng T; Dong L; Yang J; Ouyang Y; Liu S; Li L; Wang Z; Peng K; Fang X; Dai X
    J Infect; 2021 Jan; 82(1):e38-e40. PubMed ID: 33248219
    [No Abstract]   [Full Text] [Related]  

  • 18. Equivalent SARS-CoV-2 viral loads by PCR between nasopharyngeal swab and saliva in symptomatic patients.
    Yokota I; Hattori T; Shane PY; Konno S; Nagasaka A; Takeyabu K; Fujisawa S; Nishida M; Teshima T
    Sci Rep; 2021 Feb; 11(1):4500. PubMed ID: 33627730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type.
    Lephart PR; Bachman MA; LeBar W; McClellan S; Barron K; Schroeder L; Newton DW
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115200. PubMed ID: 32980807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial simultaneously self-swabbed samples from multiple sites show similarly decreasing SARS-CoV-2 loads in COVID-19 cases of differing clinical severity.
    Pan D; Sze S; Rogers B; Bron J; Bird PW; Holmes CW; Tang JW
    J Infect; 2020 Dec; 81(6):979-997. PubMed ID: 32956734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.